Cargando…

SARS-CoV-2 promote autophagy to suppress type I interferon response

Detalles Bibliográficos
Autores principales:	Hui, Xianfeng, Zhang, Linliang, Cao, Lei, Huang, Kun, Zhao, Ya, Zhang, Yufei, Chen, Xi, Lin, Xian, Chen, Mingzhou, Jin, Meilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105701/ https://www.ncbi.nlm.nih.gov/pubmed/33966045 http://dx.doi.org/10.1038/s41392-021-00574-8

Ejemplares similares

In vitro and in vivo effects of 3-indoleacetonitrile—A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection
por: Hui, Xianfeng, et al.
Publicado: (2023)

SARS-CoV-2 Rapidly Adapts in Aged BALB/c Mice and Induces Typical Pneumonia
por: Zhang, Yufei, et al.
Publicado: (2021)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice
por: Huang, Kun, et al.
Publicado: (2021)

A serological survey of SARS-CoV-2 in cat in Wuhan
por: Zhang, Qiang, et al.
Publicado: (2020)

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
por: Jiang, He-wei, et al.
Publicado: (2020)

SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation
por: Zhang, Dianqi, et al.
Publicado: (2023)

Type I interferons and SARS-CoV-2: from cells to organisms
por: Bastard, Paul, et al.
Publicado: (2022)

YWHAG inhibits influenza a virus replication by suppressing the release of viral M2 protein
por: Mao, Haiying, et al.
Publicado: (2022)

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
por: Chen, Xi, et al.
Publicado: (2021)

Autophagy proteins suppress protective type I interferon signaling in response to the murine gut microbiota
por: Martin, Patricia K., et al.
Publicado: (2018)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
por: Mu, Jingfang, et al.
Publicado: (2020)

AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
por: Wang, Shengyu, et al.
Publicado: (2017)

Type I Interferons, Autophagy and Host Metabolism in Leprosy
por: Toledo Pinto, Thiago Gomes, et al.
Publicado: (2018)

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)

Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells
por: Yang, Zening, et al.
Publicado: (2022)

Inhibition of SARS–CoV-2 by type I and type III interferons
por: Felgenhauer, Ulrike, et al.
Publicado: (2020)

Interplay between SARS-CoV-2 and the type I interferon response
por: Sa Ribero, Margarida, et al.
Publicado: (2020)

Antiviral activities of type I interferons to SARS-CoV-2 infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Type I and III interferon responses in SARS-CoV-2 infection
por: Kim, You-Me, et al.
Publicado: (2021)

P300-mediated NEDD4 acetylation drives ebolavirus VP40 egress by enhancing NEDD4 ligase activity
por: Zhang, Linliang, et al.
Publicado: (2021)

SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3
por: Fung, Sin-Yee, et al.
Publicado: (2021)

Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
por: Lin, Jing-wen, et al.
Publicado: (2021)

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
por: King, Cecile, et al.
Publicado: (2021)

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
por: Bills, Cody J., et al.
Publicado: (2023)

Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cells
por: ZHAO, JUN, et al.
Publicado: (2014)

Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2
por: Aliyari, Saba R., et al.
Publicado: (2022)

Crosstalk Between Autophagy and the cGAS–STING Signaling Pathway in Type I Interferon Production
por: Zhang, Kunli, et al.
Publicado: (2021)

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
por: Schuhenn, Jonas, et al.
Publicado: (2022)

SARS-CoV-2 and interferon blockade
por: Diamond, Betty, et al.
Publicado: (2020)

hnRNPH2 as an Inhibitor of Chicken MDA5-Mediated Type I Interferon Response: Analysis Using Chicken MDA5–Host Interactome
por: Lin, Xian, et al.
Publicado: (2020)

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
por: Vanderwall, Elizabeth R., et al.
Publicado: (2022)

Suppression of Type I Interferon Signaling by Flavivirus NS5
por: Thurmond, Stephanie, et al.
Publicado: (2018)

Type I interferons induce autophagy in certain human cancer cell lines
por: Schmeisser, Hana, et al.
Publicado: (2013)

Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity
por: Tian, Yu, et al.
Publicado: (2019)

SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage
por: Sui, Yongjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ik18o6ftj3qg4n8r6n876m25vf